Autolus Therapeutics (AUTL) EBT Margin (2017 - 2025)
Historic EBT Margin for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to 370.79%.
- Autolus Therapeutics' EBT Margin changed N/A to 370.79% in Q3 2025 from the same period last year, while for Sep 2025 it was 430.66%, marking a year-over-year increase of 22444500.0%. This contributed to the annual value of 2165.36% for FY2024, which is 101080200.0% up from last year.
- Autolus Therapeutics' EBT Margin amounted to 370.79% in Q3 2025.
- In the past 5 years, Autolus Therapeutics' EBT Margin registered a high of 203.03% during Q4 2022, and its lowest value of 90151.72% during Q4 2024.
- Moreover, its 5-year median value for EBT Margin was 2443.96% (2023), whereas its average is 13494.84%.
- Over the last 5 years, Autolus Therapeutics' EBT Margin had its largest YoY gain of 192597400bps in 2023, and its largest YoY loss of -94925400bps in 2023.
- Autolus Therapeutics' EBT Margin (Quarter) stood at 16684.75% in 2021, then skyrocketed by 99bps to 203.03% in 2022, then tumbled by -5465bps to 11298.03% in 2023, then crashed by -698bps to 90151.72% in 2024, then surged by 100bps to 370.79% in 2025.
- Its last three reported values are 370.79% in Q3 2025, 227.12% for Q2 2025, and 756.36% during Q1 2025.